President Nana Addo Dankwa Akufo-Addo has said the decision why Ghana approved the malaria vaccine developed by scientists at Oxford University because the vaccine has proven to be safe.
The vaccine (vaccine-R21) according to the government would be administered to newborns and kids up to three years.
Speaking at the inauguration of the DEK Manufacturing Plant in Accra, President said
“The approval was granted following an extensive series of reviews and further peer reviews of the non-clinical and clinical quality parts of the vaccines. The R21 malaria vaccine has been approved for use for the immunisation of children between 5 months and 36 months against malaria.”
The vaccine was developed by Oxford University and manufactured by the Serum Institute of India.
Ghana’s Food and Drugs Authority has granted market authorisation to the new malaria vaccine – R2 after a thorough evaluation of the quality, efficacy, and safety of the vaccine, it realized that the benefits far outweigh the risks.